(Q74535647)

English

Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer

scientific article published on 01 December 2000

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

title

Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

main subject

phase I clinical trial

1 reference

S S Agarwala

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

J M Kirkwood

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

J Bryant

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

publication date

1 December 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

published in

Cytokines, Cellular & Molecular Therapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

page(s)

171-176

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Identifiers

DOI

10.1080/MCCM.6.4.171.176

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PubMed publication ID

11565955

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11565955

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11565955%20AND%20SRC:MED&resulttype=core&format=json

(Q74535647)

Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)